Plus (NASDAQ: PLUS) reported its financial results for the fourth quarter of 2024, revealing a miss on both earnings and ...

Reports Q4 revenue $10.499B, consensus $10.32B. “I am very pleased our 2024 revenue growth exceeded our long-term targets and we produced ...

Reports Q4 revenue $2.39B, consensus $2.47B. “Oscar reported positive full year 2024 results, capping the strongest year of financial ...

The insurer also reported notable ACA growth for this year, though membership could tick back down through the second quarter ...

Equities research analysts at Zacks Research lowered their Q2 2025 earnings estimates for Elevance Health in a research ...

Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

Jack Meehan; Analyst; Nephron Research Erin Wright; Analyst; Morgan Stanley ...

During Q4 2024, global stocks were pressured by investor concerns about economic growth and persistent inflation in some regions & despite potential for further interest rate cuts in 2025.

CEO Jim Davis reported a nearly 15% revenue growth for Q4, including 5% organic growth, and close to 7% revenue growth for the full year, supported by eight acquisitions. He highlighted the Advanced ...